Compare VRDN & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRDN | OBK |
|---|---|---|
| Founded | 2006 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2014 | 2018 |
| Metric | VRDN | OBK |
|---|---|---|
| Price | $16.25 | $46.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 6 |
| Target Price | $35.46 | ★ $46.67 |
| AVG Volume (30 Days) | ★ 3.2M | 107.5K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.89 |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $13.73 | $26.43 |
| Revenue Next Year | $279.00 | $5.79 |
| P/E Ratio | ★ N/A | $53.54 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.18 | $32.13 |
| 52 Week High | $34.29 | $48.65 |
| Indicator | VRDN | OBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 51.02 |
| Support Level | $15.65 | $45.06 |
| Resistance Level | $18.05 | $48.19 |
| Average True Range (ATR) | 0.83 | 0.97 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 23.73 | 45.90 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.